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STUDY OF 3-UTR OF INDUCIBLE NITRIC OXIDE SYNTHASE AND ID. OF 
OTHER TARGETS OF GAIT PATHWAY 
ABSTRACT 
VADLAMANI SIRISHA 
Macrophages and other leukocytes play a vital role during inflammation. IFN- which is 
secreted by Th1 cells activates monocyte-macrophages and this activation leads to 
induction as well as suppression of certain genes expressed during inflammation. This 
suppression of genes may be potentially vital for resolution of inflammation. Upon IFN-γ 
stimulation, a Gamma-activated inhibitor of translation complex (GAIT) is formed, 
which binds to 3-UTR of target mRNAs thereby silencing their translation. VEGF-A and 
ceruloplasmin are two proteins whose translation is suppressed by this pathway. The 
GAIT complex proteins have been identified as ribosomal protein L13a, glutamyl-prolyl 
tRNA synthatase (EPRS), NS-1 associated protein 1 (NSAP-1), and glyceraldehyde-3 
phosphate dehydrogenase (GAPDH) (Mazumder et al., 2003; Sampath et al., 2004). The 
cellular abundance of the proteins involved in GAIT complex formation is in excess of 
Cp or VEGF mRNA, so we hypothesize that there exists additional mRNAs that are 
subject to GAIT-mediated translational control. Hence further studies were done to 
investigate other possible targets of this pathway. A probable list of targets containing 
putative GAIT-like elements in 3-UTR were obtained using pattern search, a 
bioinformatic approach (Ray and Fox, 2007). Among these targets, inducible nitric oxide 
synthase (iNOS) was found to be of particular interest as nitric oxide which is produced 
by enzymatic activity of nitric oxide synthases, is central for the function of macrophages 
 vi 
and also for early immune responses to invading microorganisms. Apart from iNOS, 
translational silencing of putative GAIT element  bearing mRNAs  of ADAM10, 
GLUT10, LITAF, GABA B receptor and mouse iNOS in their 3-UTR was also 
investigated in IFN- treated monocytic cells which suggests that there might be 
additional targets of this pathway.  
 vii 
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CHAPTER I 
INTRODUCTION 
1.1 Introduction to Translation in Eukaryotes: 
Translation of mRNA into protein represents the final step in gene expression i.e. 
formation of a proteome from genomic information. The structure and metabolism of 
eukaryotic mRNAs differ substantially from that of prokaryotes.  
 
 
 
 
 
Figure 1: Nuts and Bolts of mRNA 
Eukaryotic mRNAs are usually capped, polyadenylated and generally encode a single 
protein, i.e., they are monocistronic. The transcription and processing events are 
separated from translation by a nuclear membrane. Thus mature completely formed 
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mRNA are presented in the cytoplasm. These mRNAs possess secondary structures in 
both the 5 and 3-UTR that regulate the translation of the protein as shown in Figure 1. 
Translation is accomplished by ribosomes, large ribonucleoprotein (RNP) assemblies of 
approximately 4mDa in association with large number of accessory factors (Zhang et al., 
2006). In eukaryotes mRNAs exists as mRNP (ribonucleoprotein particles). Thus 
mRNAs are either present as non-active mRNPs or actively translating mRNPs. Bacterial 
mRNAs have a rapid turnover hence it is difficult to isolate individual mRNA and 
translate it in vitro; in contrast eukaryotic mRNAs can be isolated either individually or in 
group and can be translated in vitro.  
Initiation in eukaryotes is accomplished by specialized cap-binding initiation factor that 
binds to mRNA and positions it on the small ribosome subunit. Usually AUG after the 
cap is used as the initiation codon. 
Translation is a process by which the information contained in the nucleotides is 
converted into polypeptide. This process is divided into three phases: initiation, 
elongation and termination. All of the three steps depend on the protein-protein, protein-
RNA and RNA-RNA interactions. The first step in translation initiation is the formation 
of a ternary complex consisting of eIF2, GTP and Met-tRNAi
Met
. This binding is 
stabilized by eIF1A and eIF3. Met-tRNAi
Met
 is delivered directly to the A site unlike the 
other amino acids which enter P site.The mRNA processing events such as capping, 
splicing and polyadenylation start when the RNA polymerase II is still engaged in 
elongation. Various enzymes involved in RNA processing (Such as capping enzyme, 
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components of splicing machinery and cleavage and polyadenylation factor) are recruited 
by C-terminal domain of RNA Polymerase II.  
1.2 Translation Control of Gene Expression: Global or Transcript Specific: 
Translational control of gene expression is specially important during development and 
cell differentiation or during stress. It can be global translational control like 
phosphorylation and inactivation of eIF2α by kinases such as Heme regulated inhibitor of 
translation (HRI) activated by heme or iron deficiency, double-stranded RNA regulated 
protein kinase (PKR) activated by viral infection or double-stranded RNA, PKR-like 
endoplasmic reticulum kinase (PERK) activated by unfolded proteins in ER, or GCN2 
activated by amino acid deficiency (GCN2) respectively (Dever, 2002; Zhang et al., 
2006). In case of transcript specific translation control the trans-acting factors usually 
recognize certain cis-acting sequences present in 3 or the 5-UTR of the mRNA. 
miRNAs also can aid in regulation of translation by hybridizing to 3-UTR of mRNAs 
thereby inhibiting the elongation / termination of peptide synthesis (Olsen P H et 
al.,2002). The cis-acting elements are usually stem loop structures and have specific 
sequence requirements for silencing activity. The presence of such sequences in multiple 
mRNAs recognized by same RNA-binding complex suggests that this can be operated as 
a post-transcrptional regulon controlling the translation of certain protein families or 
functionally related proteins.  
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Figure 2: Activation of GAIT complex by IFN- treatment 
Translational control of ceruloplasmin provides an example of transcript-specific 
translational silencing. Ceruloplasmin mRNA is circularized by its binding of poly(A) 
binding protein (PABP) to the poly(A) tail in the 3-UTR and to eIF4G during the 
translation initiation process. Upon stimulation by IFN-γ a heterotetrameric GAIT 
complex is formed which binds to the GAIT element present in 3-UTR of Cp and 
phosphorylated L13a which is  a part of heterotetrameric complex binds to eIF3 binding 
site of eIF4G thus blocking the assembly of 48S ribosomal complex (Sampath P et al., 
2004, Kapasi P et al., 2007). Similarly a gene which plays an important role in 
angiogenesis i.e., VEGF-A was also found to be translationally controlled by GAIT 
pathway (Ray and Fox 2007).  
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CHAPTER II 
GAIT PATHWAY 
2.1 GAIT Complex Components and Structure of GAIT element: 
The GAIT complex components have been identified as glutamyl-prolyl tRNA-
synthatase (EPRS), ribosomal protein L13a, NS-1 associated protein 1 (NSAP1) and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Mazumder et al., 2003; Sampath 
et al., 2004). EPRS is phosphorylated and released from multisynthetase complex and 
phosphorylated L13a is released from the large 60S ribosomal subunit.  
 
Figure 3: Predicted Structure of GAIT element (Sampath et al, 2003) 
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GAIT complex is assembled in two stages: in the first step after 2 to 4 hrs of IFN- 
treatment EPRS binds NSAP1 to form pre-GAIT complex which cannot bind the GAIT 
element. In the second step phosphorylated L13a and GAPDH join the pre-GAIT 
complex after 12 hrs to form active GAIT complex (Jia et al., 2008) (Figure 2). 
Sampath et al. have shown that a 29 nucleotide (nt) element found in 3-UTR of Cp 
mRNA is the minimal sequence required for binding of the GAIT-complex and 
subsequent silencing. Mutation analysis has shown that GAIT element has certain 
structural as well as sequence requirements. The element has a 5-nt terminal loop 
separated from an asymmetric bulge by a short 3-nt stem. The entire structure is held by a 
proximal 6-nt double helical stem. It has invariant U and A nucleotides in the asymmetric 
bulge (Sampath et al., 2003, Mazumder et al., 2003). 
2.2 Ceruloplasmin and VEGF-A regulation by GAIT pathway: 
Ceruloplasmin is a glycoprotein which is primarily synthesized by liver in adult humans. 
IFN-γ stimulation of ceruloplasmin is cell type specific and it contributes to the defense 
responses by its ferroxidase activity. IFN-γ stimulates ceruloplasmin production 
differently in several cell types (Mazumder et al., 1997).  
IFN-γ induces ceruloplasmin synthesis in U937 monocytic cells (Mazumder and Fox, 
1999) and its protein expression is halted in a delayed silencing process. This silencing 
process, apart from binding of GAIT complex to mRNA, requires interaction between 
eukaryotic initiation factor 4G, poly(A) binding protein and poly(A) tail (Mazumder et 
al., 2003). 
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Figure 4: GAIT element structure of Ceruloplasmin and VEGF 
The very high cellular abundance of four GAIT complex components and the 
stoichiometric release of L13a and EPRS from respective parent complexes is much in 
excess of Cp mRNA. Hence it has been speculated that there exists additional targets 
which are regulated by GAIT pathway. Further investigations were done to identify 
potential targets of GAIT mediated pathway. The 3-UTR database was searched using 
the Cp GAIT element sequence and secondary structure information and VEGF-A was 
found to be of particular interest (Ray and Fox, 2007). 
VEGF-A expression is regulated by hypoxia and cytokines at the levels of transcription, 
mRNA stability and translation. GAIT mediated pathway of VEGF-A regulation is the 
first identified negative regulatory mechanism. It has been shown in our laboratory that 
GAIT complex suppresses VEGF-A expression in IFN- activated monocytic cells such 
as U937 and PBMCs by inhibiting its translation (Ray and Fox, 2007).  
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2.3 Mfold and Patsearch programs to predict the structures of putative GAIT targets: 
The mfold program for RNA folding was used to predict the secondary structures of 
RNA when folded under simulated physiological conditions. This program folds the 
RNA at 37C and it calculates the minimum free energy for any particular folding and the 
base pairs that it must contain. This program also gives the flexibility to use certain 
constraints to fold the RNA with a limitation that the free energy of the newly formed 
structure does not differ too much from the one formed under unrestricted conditions.  
 
Figure 5: mfold predicted structures of DAPK and ZIPK GAIT elements 
Figure 5 shows the putative GAIT elements present in DAPK and ZIPK which have been 
experimentally verified (Mukhopadhyay R. et al., Molecular Cell In press) as GAIT 
targets. In ZIPK GAIT element it has been observed that it has four base pairs in the 
distal stem unlike the classical Cp GAIT element and it also had two G-C base pairs in 
this distal stem which was thought to be destabilising the Cp GAIT as found in the 
mutational analysis. It is held by a clamp of two G-C base pairs and has an G-G bulge in 
the proximal stem. 
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A GAIT element pattern, based on the sequence requirements and secondary structure of 
Cp GAIT element, was used to query a non-redundant 3-UTR database containing 217 
135 sequences using PatSearch. Patsearch is a folding energy independent, pattern 
matching algorithm that searches for nucleotide sequences as well as secondary 
structures, that is stems and loops of defined length (Ray and Fox 2007). When the 5-
UTR was used to query for presence of GAIT like elements it gave only 5 results out of 
190 432 sequences, showing that this element was present more abundantly in 3-UTR 
with specific roles. VEGF-A GAIT element was also found through this search and it was 
also particular interest as no negative regulation of VEGF-A was known in literature.  
Table 1: Partial List of Pattern Search for GAIT element in Human 3-UTRs 
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Ray et al. have performed a bioinformatic/candidate gene approach to find out the 
possible targets of GAIT-mediated pathway. In this approach U937 cells were treated 
with IFN-γ for indicated time periods and the cell lysate was immunoprecipitated with α-
EPRS. Then total RNA was isolated from it and was subjected to reverse transcription 
using oligo(dT) primers, this cDNA was sent for Microarray analysis. Among the results 
obtained inducible nitric oxide synthase was found to have highest mean fold enrichment 
IP/Total RNA, hence it was further investigated to test for presence of GAIT element in 
its 3-UTR. 
Further insight into the GAIT mediated pathway was obtained by Mukhopadhyay et al 
with the finding of death-associated protein kinase that activates zipper-interacting 
protein kinase which further phosphorylates L13a on Ser
77. 
This phosphorylated L13a is 
released from the ribosome thereby forming the GAIT complex and silencing the 
translation of target proteins. Thus the mRNAs of the kinases of GAIT mediated pathway 
are themselves translationally silenced by this pathway hence it constitutes a 
autoregulatory mechanism (Mukhopadhyay R  et al., Molecular cell in press ). 
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CHAPTER III 
INDUCIBLE NITRIC OXIDE SYNTHASE 
3.1 Structure and Function of Inducible Nitric Oxide Synthase: 
Nitric oxide synthases (NOS) are present as dimers in eukayotes. They are of three types 
(a) inducible NOS (b) neuronal NOS and (c) endothelial NOS encoded by three different 
genes. iNOS has been implicated in the pathogenesis of various diseases such as 
Alzheimer’s disease, tuberculosis, asthma, glaucoma, inflammatory bowel disease, 
arthritis, stroke and septic shock (Jagannath C et al., 1998).  
 
Figure 6: Enzymatic activity of Nitric oxide synthases 
Macrophages are important for early immune responses against invading microorganisms 
and the production of nitric oxide (NO) is central to this function. NO is generated by 
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inducible nitric oxide synthase (iNOS or macNOS or Type II NOS) following exposure 
to certain cytokines, such as interferon- (IFN-) as depicted in Figure 7. IFN- a Th1 
cytokines activates cytotoxic T lymphocytes, natural killer (NK) cells and macrophages. 
The IFN-γ receptor signals through the Janus kinase (JAK) family and signal transducers 
and activators of transcription (STAT) proteins. Receptor occupation and dimerization 
induces the phosphorylation of associated STATs. Activated STATs dimerize and 
translocate to the nucleus where they increase expression of the transcription factor, IRF-
1, that, in turn binds to specific DNA elements in the iNOS gene promoter region to 
increase iNOS gene expression (Massa P. T et al., 1998;  Fehr T., et al., 1997). 
 
 
Figure 7: Transcritional upregulation of iNOS by cytokines 
(Massa P. T et al., 1998;  Fehr T. et al., 1997) 
 13 
Inducible nitric oxide synthases catalyse the conversion of L-arginine to L-citrulline 
which has different cofactor requirements. This is a two step reaction involving a two 
electron oxidation in first step to form N-hydroxy-L-arginine and a second step of three 
electron oxidation to form L-citrulline and the free radical nitric oxide (Figure 8). 
 
Figure 8: Chemistry of iNOS enzymatic activity 
iNOS is a soluble enzyme that, unlike eNOS and nNOS, does not require elevated 
intracellular Ca
2+
 levels for activation. The NOS enzymes have three different domains: a 
reductase domain, a calmodulin-bindng domain and an oxygenase domain (Figure 9).  
a) The reductase domain: This domain consists of FAD, FMN moieties and transfers 
electrons from NADPH to oxygenase domain. Here one reductase domain will aid in 
transfer of electrons to oxygenase domain of another subunit.  
b) Calmodulin binding: This binding is required for the activity of the enzyme and it 
detects changes in intracellular calcium levels. 
c) The oxygenase domain: The binding domains for heme, arginase and 
tetrahydrobiopterin are present in this domain. It also catalyses the conversion of arginine 
into citrulline and NO. 
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Figure 9: Structure of iNOS dimer (Adapted from www.sgul.ac.uk/dept/immunology) 
The human iNOS contains 26 exons and encodes a 131 KDa protein. Intracellular iNOS 
largely exists as a soluble cytosolic fraction. It is expressed in macrophages, monocytes, 
leukocytes, endothelium, smooth muscle, neutrophils, retinal pigmented epithelium, 
astrocytes, microglial, hepatocytes, kupfer cells, fibroblasts and mesangium (Berthlot S et 
al., 1999). It has been known that iNOS is transcriptionally upregulated by LPS and 
certain cytokines in murine cell line. There are no reports on the translation regulation of 
inducible nitric oxide synthase in monocytic cells, hence we further investigated the 
effect of IFN- treatment and its relationship to GAIT-mediated pathway in human 
monocytic cell line i.e. U937 cells. 
From the results of bioinformatic approach which has given a probable list of mRNA 
with putative GAIT like elements, inducible nitric oxide synthase was found to be the 
gene with highest mean fold enrichment IP/Total RNA (Ray and Fox 2007). Thus the 
detailed sequence analysis of iNOS mRNA was done which shows that it has ‘CA-rich’ 
nucleotide sequence ahead of mfold predicted GAIT like structure. This suggests that like 
VEGF-A, iNOS may also be regulated by both IFN- and hypoxia. We further 
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investigated the effect of iNOS 3-UTR in translational control with a primary goal to 
study the effect of IFN- activation in monocytes. 
3.2 Study of 3-UTR of human and Mouse iNOS for presence of GAIT element: 
It has been reported that VEGF-A 3-UTR has a sequence which behaves as a riboswitch 
that integrates signals from hypoxia and IFN-γ to regulate VEGF-A translation in 
myeloid cells (Ray P. S. et al., Nature In press). The VEGF-A 3-UTR has a hypoxia 
stability region (HSR) that binds hnRNP L and confers hypoxia mediated stability to 
mRNA. hnRNP L  protein has high affinity to bind to CA-repeat sequence (Hui J et al., 
2003), VEGF-A mRNA has a A/C rich sequence which corresponds to hnRNP L binding 
site. 
Previous studies on mouse iNOS 3-UTR has shown that inflammation effects the 
interaction of heterogenous ribonucleoproteins i.e. hnRNP L and hnRNP I/PTB with 
mouse iNOS 3-UTR (Soderburg M. et al., 2002). The 3-UTR sequences of Mouse and 
human iNOS are 473 and 477 bp respectively. The Mouse iNOS hnRNP L binding site is  
434-456bp and a mfold predicted GAIT element of mouse iNOS was found to be located 
from 435-467bp (Figure 10). The hnRNP L binding region was encompassed within the 
binding site of GAIT element. A further alignment of mouse iNOS 3-UTR region with 
that of human iNOS 3-UTR has shown that there is about 83% of sequence homology 
between them particularly in the extreme 3 region where the mouse hnRNP L binding 
domain was located. 
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Figure 10: mfold predicted putative Mouse iNOS GAIT-like element 
Thus a further investigation was done on human iNOS 3-UTR was done to see if it able 
to confer translational silencing to Luciferase reporter construct. 
Mouse iNOS 3-UTR sequences of GAIT-like element, hnRNP L binding sequence 
 
Sequence homology between Mouse iNOS and Human iNOS 3-UTR 
  Query (mouse iNOS) 
  Subject (Human iNOS) 
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3.3 Study of other targets for presence of GAIT-like element: 
Earlier data on GAIT mediated silencing has shown that the protein expression is 
silenced in U937 cells treated with IFN-γ for 24hr (Mazumder et al., 2003; Ray and Fox, 
2007). Based on the results obtained from pattern search analysis and Bioinformatic 
approach a list of proteins associated with inflammation and which had a high IP/Total 
RNA in RIP-ChIP analysis were identified for further investigation. 
A preliminary western blotting was done to observe the protein expression pattern in 
IFN- treated U937 cells at 0,8 and 24hr for ADAM10, GLUT10, LITAF, GABA B 
receptor and mouse iNOS.  
γ-aminobutyric acid is a major neuroinhibitory transmitter in the mammalian central 
nervous system but recent studies have shown that it is located in nonneuronal cells in 
peripheral tissue(Osawa Y., et al., 2006). It is composed of two subunits and is functional 
only when both the subunits are expressed and the heterodimer assembly is complete. In 
the present study we investigated for the presence of GABAB receptor expression in 
monocytic cells. Further studies may provide insight into functional characerization for 
its presence in monocytic cells.  
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CHAPTER IV 
METHODS 
Reagents 
Rabbit reticulocyte lysate, methionine-minus amino acid mixture and RnaseIn were 
purchased from Promega (Madison, WI, USA). Human IFN- from R&D systems 
(Minneapolis, MN, USA), [35S] methionine was purchased from Perkin-Elmer for in 
vitro translation (translation grade).  
Cell Culture 
Human U937 monocytic cells were cultured in RPMI 1640 medium supplemented with 
10% heat inactivated fetal bovine serum (FBS), 100 units/ml penicillin, 100 units/ml 
streptomycin and 2mM L-glutamate. Cells were maintained in a humified atmosphere 
containing 5% CO2 at 37º C.  U937 cells were treated with 500U/ml of IFN- for the 
times indicated. The iNOS 3´UTR was amplified from total RNA obtained from U937 
cells and cloned into pGEMT vector (Promega, Madison, WI, USA). The DNA fragment 
was inserted downstream of FLuc, in the vector pSP64-FLuc to obtain pSP64-FLuc-
iNOS 3´UTR. 
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Preparation of cell extracts 
Two days before treatment, the cells were passaged in a dilution of 1:5 per flask. Cells 
were seeded on 60-mm Petridish, they were preincubated in 0.5% serum for 1 hour and 
treated with 500U/ml of IFN- for an additional 8 and 24 hours, harvested by scraping 
and the cells were washed in ice-cold D-PBS. The cells were collected by centrifugation 
at low speed and the cell pellet was suspended in a mixture of 50mM Tris (pH 7.6), 
50mM NaCl, 1mM PMSF and 1mM DTT and was passed through 26-gauge syringe 
several times and incubated on ice for 10 minutes, ultracentrifuged at 100,000 X g for 30 
minutes. The protein concentration was assayed using Biorad reagent with bovine serum 
albumin as standard, adjusted to 1mg/ml and 500ng was used in the in vitro translation 
reaction.  
Total RNA isolation and Semi-Quantitative RT PCR 
Total RNA was isolated from cells treated with IFN- using Trizol reagent according to 
the manufacturer’s instructions. Total RNA was first extracted using Trizol followed by a 
chloroform extraction. RNA was then precipitated from the aqueous phase by mixing 
with isopropanol, the precipitate was washed with 75% ethanol and then suspended in 
RNase free water. To eliminate any possibility of DNA contaminations in the RNA 
preparations, samples were digested with 1U DNase I and 1l of DNase buffer 10X 
(Promega, Madison, USA) per g of RNA was incubated with each sample for 15 
minutes at room temperature. The reaction was stopped by adding stop reaction mix. 
Phenol:Chloroform extraction was performed to separate RNA followed by precipitation 
with sodium acetate and ethanol 100%. The precipitate was washed with 75% ethanol 
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and suspended in RNase free water. Then 1g of RNA was reverse transcribed using 
Oligo(dT) primers. cDNA was subjected to PCR amplification by primers designed for 
amplification of full length 3-UTR. The optimal number of cycles and the temperature 
for amplication, annealing time, extension time were determined in a first few 
preliminary experiments designed to detect iNOS expression in IFN- treated U937 cells. 
It was then normalized to amplified -actin cDNA. 
Construction of vectors containing iNOS 3 UTR and Fluc in pSP64 
The iNOS 3UTR consisting of 475 bp was cloned with BamHI and SacI restriction sites 
at the 5 and 3 ends respectively . The 495bp was then inserted into pSP64 in the 
corresponding restriction site. The Luciferase gene was cut from pcDNA3 which has 
HindIII and XhoI restriction ends at 5 and 3 ends respectively and cloned into pSP64 
vector containing iNOS 3UTR between HindIII and SalI sites. Thus the recombinant 
reporter gene containing the iNOS 3UTR downstream of FLuc was made. A set of intron 
spanning primers were designed to ensure that there is genomic DNA contamination in    
the total RNA isolated. 
The following are the set of primers used for amplification of iNOS cDNA isolated from 
Total RNA of IFN- treated U937 cells: 
 FP with Stu I (5-3): TAA TAGGCCTCT ACA GGA GGG GTT AAA 
 FP with BamHI (5-3): TTAAGGATCCCCTACAGGAGGGGTTAA 
 RP with Sac I (5-3): GGG CGAGCTCGT GAT TAA AGT AAA ATG 
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 iNOS intron spanning FP (5-3): GCA TGA CCT TGG TGT TTG GGT 
 iNOS intron spanning RP (5-3): TTC AAT TTC AGC TTG GCA GCC 
In vitro transcription of iNOS 3-UTR 
pSP64 plasmid constructs containing VEGF-A 3´-UTR or iNOS 3´-UTR sequences 
downstream of FLuc were linearised by digesting it with BamH1 and transcribed in vitro 
using the mMessage mMachine transcription system (Ambion, Austin, TX, USA) to 
generate capped poly(A) tailed RNAs. Capped RLuc was similarly transcribed from the 
plasmid pRL-SV40 (Promega). 
In vitro translation of mRNA by reticulocyte lysate 
For in vitro translation (12.5l reaction) 200ng of RLuc, 300ng of FLuc-iNOS 3-UTR, 
40units of RnaseIn, 8.75l of rabbit reticulocyte, 0.3l of minus Met amino acid mixture, 
0.75l of 35S Met were incubated for 90 minutes at 30º C. Capped poly(A) template 
RNAs were translated in RRL (Promega) in the presence of a methionine-free amino-acid 
mixture and translation-grade [35S] methionine (Perkin Elmer, Boston, MA, USA). 
Cyotsolic extract (500ng protein) from untreated of IFN- treated cells were added to 
translation reactions. A 5l reaction was resolved by SDS-PAGE (10% polyacrylamide), 
fixed in 40% methanol and 10% acetic acid solution for 15- 20 minutes and visualized by 
phosphorimaging. 
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Immunoblot analysis of iNOS 
Cell lysates were denatured under nonreducing conditions, and resolved on SDS-PAGE. 
After transfer the blot was probed with anti-human iNOS antibody and HRP conjugated 
anti-rabbit secondary antibody, and detected by ECL (Amersham, Arlington Heights, IL, 
USA). Immunoblotting was also done by anti-VEGF as a positive control and anti-
GAPDH to ensure equal loading. 
Nitrite Assay 
Nitric oxide is a molecular mediator of many important physiological processes such as 
vasodilation, inflammation, thrombosis, immunity and neurotransmission. Owing to its 
very short half-life (milliseconds) accumulation of stable degradation products such as 
Nitrite or Nitrate are taken as an index to measure the NO levels. Griess reagent is used in 
one of these methods to assay for nitrite (NO2
-
). This assay is based on diazotization 
reaction as described by Greiss. In this reaction sulfanilamide is converted into a 
diazonium salt by reaction with nitrite in acid solution. The diazonium salt is then 
coupled to N-(1-naphthyl)ethylenediamine, forming an azo dye that can be 
spectrophotometrically quantitated based on its absorbance at 548nm. This can be used to 
detect NO2 in a variety of biological systems such as plasma, urine and tissue culture 
medium. Nitrite standards were prepared in the range of 1-100M using sodium nitrite. 
For each reaction 100l of Greiss reagent, 300l of the nitrite-containing sample and 
2.6mL of deionized water were mixed in a cuvette. This mixture was incubated at room 
temperature for 30 minutes. A reference sample was made by mixing 100l of Greiss 
reagent with 2.9mL of water. The absorbance of nitrite containing sample was measured 
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at 548nm relative to the reference sample. Different concentrations of sodium nitrite 
solution were prepared and whose absorbance was taken at 548 nm; A standard curve 
was plotted for different concentrations and the observed absorbance. The unknown 
concentrations of the samples were calculated from the standard curve and a graph 
representing the trend of NO levels in the U937 cells treated with IFN-γ and untreated 
cells.   
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CHAPTER V 
RESULTS 
IFN- stimulated production of iNOS mRNA by the human macrophage cell line U937  
Previous studies in our lab have shown that Cp and VEGF mRNA levels are increased by 
IFN- treatment which contain functional GAIT element. To determine whether or not 
iNOS mRNA is similarly stimulated by IFN-, U937 cells were treated with IFN- for 0, 
8 and 24 hours and the total RNA was isolated using Trizol reagent.   
 
Figure 11: RT-PCR of iNOS gene and GAPDH control using gene specific primers  
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RT-PCR was performed using iNOS specific and Actin primers. Semi-Quantitative PCR 
has shown a 2.6-fold increase in iNOS mRNA at 8 hrs and 2.8-fold increase at 24hrs; 
Once the message levels of iNOS mRNA was determined at different time points, the 
next step was to check for its protein levels in vivo. 
To determine the function of iNOS 3UTR in translational silencing in IFN- treated 
monocytic cells 
To investigate the role of iNOS 3UTR in translational silencing endogenously, cells were 
treated with IFN-γ for the indicated time periods and cell lysates were processed in 
Laemlli gel-loading buffer in the presence of reducing agent. Lysates were then subjected 
to immunoblotting with anti-iNOS. It has been observed in RT-PCR that the message 
levels are upregulated in response to IFN- treatment by 2.6- and 2.8-fold respectively.  
      
Immunoblot analysis of iNOS and VEGF-A
as normalized to GAPDH
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Figure 12: Western blotting result of iNOS gene using GAPDH and VEGF-A as controls 
Likewise cellular iNOS protein expression was also increased at 8hr but as in case of 
VEGF-A or Cp there was no down-regulation seen at 24 hrs. In VEGF-A and Cp which 
contain functional GAIT element, the protein synthesis was silenced by more than 50% 
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after 24hrs. To conform the presence of functional GAIT complex in these cell lysates, 
VEGF-A protein levels were assessed at 0, 8 and 24 hrs and GAPDH was used as a 
loading control. It has been observed that VEGF-A protein evels has gone down at 24hr 
in contrast to iNOS expression which has been upregulated. 
To check for translation silencing in rabbit reticulocyte lysate 
To check for the translational levels of iNOS in cell-free rabbit reticulocyte lysate in the 
presence of 
35
S-Met; iNOS 3-UTR was cloned downstream of Firefly Luciferase open 
reading frame inserted in pSP64 vector and its translation levels were seen in in vitro 
translation system. A capped, poly(A)-tailed RNA transcribed in vitro and used as a 
template for translation in rabbit reticulocyte  lysate (RRL) system. The FLuc-Cp GAIT-
A30 was used as a positive control to confirm the formation of functional GAIT complex 
in cell lysate.  
 
Figure 13: In vitro translation of pSP64-Fluc-NOS and pRL in rabbit reticulocyte lysate 
Lysates from cells treated with 24 hrs of IFN- have shown to inhibit Cp synthesis but 
not FLuc-iNOS 3-UTR in conformance with what was seen in western blot. Translation 
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of capped Renilla Luciferase (RLuc) RNA lacking the 3-UTR segment was used as a 
control template, was not inhibited. 
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Figure 14: Fluc quantified by densitometry normalized to Rluc and expressed as a percent 
of control without cell lysate 
Inhibition of a protein synthesis by GAIT complex is highly sequence specific as seen in 
case of Cp and VEGF-A. Lack of inhibition of iNOS protein suggests that it may lack the 
specific sequence required for silencing. Translation upregulation was seen during the 
time course of 0, 8 and 24hr in FLuc-iNOS 3-UTR in contrast to translational silencing 
of VEGF-A or Cp as seen from the previously published work. 
Assay for Nitrite in cell culture supernatant 
To investigate the activity of iNOS in vivo, assay for nitrite levels in culture supernatants 
was performed. Nitric oxide is readily oxidized to Nitrite and this can be assayed using 
Greiss reagent. As described the assay was performed according to the protocol and the 
nitrite levels were measured using sodium nitrite as standard at 548nm. A standard curve 
was generated starting with 100nM sodium nitrite concentration with increasing 
concentrations. Readings were taken in duplicate, similarly readings for the sample 
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preparations was also taken in duplicates and compared with that of sodium nitrite 
containing serial dilutions. 
Table 2: Concentrations of Sodium Nitrite standard and absorbances at 548nm 
Conc. of sodium 
Nitrite(nM) 
Abs  
(at 548nm) 
0 0 
100 0.050 
250 0.132 
500 0.232 
700 0.338 
 
Greiss Reagent assay: Sodium Nitrite standard curve
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Figure 15: Standard curve of Sodium Nitrite concentration plotted against mean of the 
absorbance at 548nm 
U937 cells were either treated with IFN- γ for 0, 8 and 24 hr respectively and the nitrite 
assay was performed using greiss reagent. Cell were treated in duplicates either with IFN- 
γ, without IFN-γ as a control set.  
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Table 3: Nitrite levels in cell culture supernatant in two different sets 
Time (hr) Mean of Set 1 
(IFN-γ treated) 
Set 2 
(Untreated cells) 
0 15.497 8.265 
8 27.896 12.398 
24 86.788 20.664 
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Figure 16: Statistical presentation of NO levels in U937 cells treated  
with IFN-γ and Untreated Cells 
 
Western blotting of other targets containing GAIT-like elements 
U937 cells were treated with IFN-γ for 0, 8 and 24 hr and the cell lysate was subjected to 
western blot analysis using different antibodies as mentioned. Analysis for VEGF-A 
protein levels using α-VEGF-A has shown that its expression is silenced at 24hr which 
shows that the functional GAIT complex has formed. The same cell lysate was used to 
blot the remaining targets ADAM10, GLUT10, LITAF, and GABAB using respective 
antibodies.  
Similarly RAW 264.7 cells were treated IFN-γ for 0, 8 and 24 hr and the cell lysate were 
tested for iNOS expression. Mouse iNOS in RAW 264.7 cells and GABAB in U937 cells 
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were found to be down-regulated by IFN-γ at 24hr. ADAM10, GLUT10 and LITAF 
protein levels were upregulated with time at 0, 8 and 24hr.  
               
Figure 17: The protein expression of the targets containing putative GAIT-like elements 
as found from pattern search and Bioinformatic approach 
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CHAPTER VI 
DISCUSSION AND FUTURE INVESTIGATIONS 
Nitric oxide which is produced by the activity of NO synthase plays a vital role in 
defense against various pathogens in macrophage-mediated immune response. iNOS is 
transcriptionally upregulated in RAW cells and human monocytes by certain cytokines 
such as IFN-γ, TNF-α, IL-1β and LPS.  Previous studies done on Mouse iNOS 3-UTR 
has shown the presence of hnRNP L binding to it (Malin  et al., 2002) and regulation of 
its expression during inflammation. Michael Zuker mfold program has shown that that 
mouse iNOS 3-UTR has GAIT-like structure and this is encompassed within the hnRNP 
L binding region. Human iNOS which is about 83% similar to mouse iNOS has a similar 
CA- repeat sequence and was also found to be transcriptionally upregulated by IFN-γ as 
seen from the message levels of iNOS in IFN- γ treated U937 cells. But the protein levels 
were also consistently increasing in-line with the message levels.  
The GAIT element present in the 3-UTR of ceruloplasmin and VEGF-A mRNA 
mediates in translational silencing of its protein expression (Mazumder et al, 1999; Ray 
and Fox 2007). The proteins involved in GAIT complex formation were found to be 
much in excess of Cp and it has been speculated that presence such elements in multiple 
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mRNAs would allow it to be operated as an post-transcriptional regulon controlling the 
expression of certain protein families. Functional GAIT elements have also been 
identified in DAPK and ZIPK which are two kinases involved in this pathway 
(Mukhopadhyay R. et al., Molecular Cell In press) creating a  autoregulatory mechanism. 
Using Cp GAIT element to query the 3-UTR database other targets containing GAIT-
like elements were listed and among these some of the targets associated with 
inflammation were further investigated to confirm for the presence of functional GAIT 
element in them. Western blotting data has shown that GABAB receptor and mouse iNOS 
may be two positive targets whose protein expression was found to be silenced at 24hrs 
in IFN- γ treated U937 cells.  
Thus this pathway provides one of the important findings in inflammation and the clinical 
significance of the genes regulated by this mechanism has made this much studied 
subject. Uncontrolled activation and expression of certain proteins might pose risk to the 
cells and this pathway provides a mechanism by which this expression is controlled as 
seen in case of Cp and VEGF-A. Mouse iNOS and GABAB whose expression was found 
to be down-regulated as seen from the results of preliminary western blotting are yet to 
be studied further. This investigation may provide an understanding of pathological 
conditions associated with GABAB / Mouse iNOS and thus lead to discovery of some 
novel targets in this pathway.     
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